Lumida
/IKT
⌘K
Inhibikase Therapeutics Inc

Inhibikase Therapeutics Inc

IKT
$2.34USD+0.43%+0.01 today

MARKET CAP

326.5M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$1
$3

Buying

4

institutions

Selling

6

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY7.77 M15.77 M+1.46 M+48.9%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY7.39 M15.00 M+780.63 K+35.1%0.69%
MM

Millennium Management LLC

Q2 2026

BUY4.03 M8.18 M+1.10 M+66.2%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY468.20 K950.44 K+296.18 K+228.9%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL316.57 K610.99 K+-11.94 K+17.7%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL74.35 K150.93 K+-1.03 M-91.8%0.00%
PA

Perceptive Advisors LLC

Q2 2026

SELL0.000.00+-4.63 M-100.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-40.38 K-100.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-17.67 K-100.0%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-16.50 K-100.0%0.00%